Do Supplement Claims Need FDA Approval?

One of the most common questions from supplement founders is whether FDA must "sign off" on product claims before launch. The short answer is that supplements follow a post-market regulatory model for most claims, but that does not mean marketing is unregulated. Understanding which claims need notification, which need authorization, and which are prohibited can save brands from costly corrections later.

Does FDA approve dietary supplements before they are sold?

Unlike new drugs, dietary supplements generally do not undergo FDA pre-market approval for safety and effectiveness. Manufacturers are responsible for ensuring products are safe and that labeling complies with applicable requirements. FDA can take action after products enter the market if claims are false, misleading, or cause the product to be an unapproved new drug. FDA dietary supplement overview summarizes manufacturer responsibilities and FDA oversight tools.

When must supplement companies notify FDA about claims?

If a company makes structure/function claims on supplement labeling, it must notify FDA within 30 days of first marketing and include the mandatory disclaimer. Notification is not the same as approval — FDA does not evaluate the claim for adequacy in the notification process. However, FDA can challenge the claim later if it is false, misleading, or converts the product into an unapproved drug.

Which supplement claims require FDA authorization?

Authorized health claims and qualified health claims linking a substance to disease risk reduction require FDA review and must use approved or qualified wording. Nutrient content claims — such as "high in calcium" — must meet specific regulatory definitions. Disease claims, drug-like claims, and new dietary ingredient notifications in certain circumstances involve separate FDA pathways. Using these claim types without authorization creates significant enforcement risk.

• Structure/function claims: notification required; pre-approval not required.
• Nutrient content claims: must meet regulatory definitions; no pre-approval but must comply with standards.
• Authorized health claims: must use FDA-approved language for specific substance-disease relationships.
• Qualified health claims: must include qualifying language reflecting scientific evidence level.
• Disease/drug claims: require FDA approval unless product is lawfully marketed as a drug.

How does FTC regulation affect supplement advertising?

Even when a claim fits within FDA categories, FTC requires that advertising be truthful and supported by competent and reliable evidence before it is disseminated. For health-related claims, FTC typically expects randomized controlled human clinical trials or an equivalent level of scientific evidence, depending on claim type and product context. FTC Dietary Supplements Advertising Guide outlines substantiation expectations for supplement marketers.

What happens if a supplement makes unapproved disease claims?

FDA frequently issues warning letters to firms marketing supplements with claims that products treat cancer, diabetes, pain conditions, and other diseases. Consequences can include mandatory corrective action, product detention, injunctions, and referral for further enforcement. Because warning letters are public, they also affect retailer relationships, investor confidence, and consumer trust.

How should brands assess claim risk before launch?

A structured risk assessment reviews each claim on labels, websites, Amazon listings, ads, and influencer briefs. Teams should classify claims by regulatory type, map substantiation files, confirm notification status, and flag implied disease language. Natascia Taken, Esq. advises documenting review dates and decision-makers so the company can demonstrate a good-faith compliance process if questions arise later.

What about new dietary ingredients and manufacturing claims?

If a product contains a new dietary ingredient (NDI) not marketed in the U.S. before October 1994, separate FDA notification requirements may apply before the ingredient is introduced. This is distinct from structure/function claim notification but is often confused during launch planning. Manufacturing claims — such as GMP compliance or third-party testing statements — must also be truthful and supported; they do not substitute for claim substantiation.

How do international sales affect U.S. claim strategy?

Many brands sell on global marketplaces while maintaining U.S.-focused websites. FDA and FTC can still reach domestic advertising directed at U.S. consumers even if fulfillment occurs overseas. Copy that is lawful in another country may still violate U.S. rules when shown to American buyers. Aligning U.S. and international claim strategy early avoids having to maintain multiple conflicting product pages.

What records should supplement brands keep for claims compliance?

Maintain copies of structure/function notifications, substantiation files, label versions, and marketing approval logs. When FDA or FTC inquires, organized records demonstrate good-faith compliance efforts. Disorganized or missing documentation can extend investigations and weaken negotiating position even when underlying claims may be defensible.

Third-party sellers and affiliate marketers can create compliance gaps if they use unauthorized claims. Brand authorization agreements should require approved copy and grant takedown rights when listings drift from permitted language.

When should a brand consult counsel about supplement claims?

Early counsel involvement is most valuable before claims are printed, indexed by search engines, or amplified by paid media. Natascia Taken, Esq. frequently helps teams restructure borderline claims during product development rather than after a warning letter or marketplace suspension forces emergency edits.

This article offers general information about FDA and FTC frameworks for supplement claims. It is not legal advice, and specific products may require individualized analysis.